Moxifloxacin Pharmacokinetic Profile and Efficacy Evaluation in Empiric Treatment of Community-Acquired Pneumonia

When antimicrobials are used empirically, pathogen MICs equal to clinical breakpoints or epidemiological cutoff values must be considered. This is to ensure that the most resistant pathogen subpopulation is appropriately targeted to prevent emergence of resistance. Accordingly, we determined the pha...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Öbrink-Hansen, Kristina, Hardlei, Tore Forsingdal, Brock, Birgitte, Jensen-Fangel, Søren, Kragh Thomsen, Marianne, Petersen, Eskild, Kreilgaard, Mads
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2015
Konular:
Clinical Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356773/
https://ncbi.nlm.nih.gov/pubmed/25666151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04659-14
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller